Results of the Phase III TROPIC global study published BRIDGEWATER, N.J., Oct. 1 (HSMN NewsFeed) — Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food…
Biopharmaceuticals, Oncology
sanofi-aventis, TROPIC study, Jevtana, cabazitaxel, prostate cancer
Posts on ‘September 30th, 2010’
Phase III Data Showing Improved Survival With Jevtana(R) (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
Elekta Launches ABAS 2.0 Autosegmentation Software Used to Plan Radiation Therapy in Patients With Cancer
GPU calculations increase contouring speed by as much as 50 percent ATLANTA, Oct. 1 (HSMN NewsFeed) — Elekta recently launched ABAS (Atlas-based Autosegmentation) TWO.0 software, which includes the Simultaneous Truth and Performance Level Estimation (S…
Devices, Oncology
Elekta, Atlas-based Autosegmentation, radiotherapy, treatment plan
Minnow Pharma Names Raymond W. Cohen as Chief Executive Officer
Pharma Device Veteran Has More Than Twenty five Years of Leadership, Entrepreneurial Experience in Health Care LAGUNA HILLS, Calif., Sept. 30 (HSMN NewsFeed) — Minnow Clinical, Inc., a developer of a novel platform technology employing radiofrequency thermopl…
Devices, Interventional, Personnel
Minnow Medical, in-stent restenosis

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.